SURMOUNT-1 Trial (New England Journal of Medicine, 2022) Randomized, double-blind, placebo-controlled 2,539 participants 72 weeks NCT04184622 Tirzepatide 5 mg -16.0% Mean body weight reduction Tirzepatide 10 mg -21.4% Mean body weight reduction Tirzepatide 15 mg -22.5% Mean body weight reduction Placebo group: -2.4% All results statistically significant (p 27 with Comorbidities Overweight or obese patients (Indian cutoff BMI 23+ with risk factors) seeking significant, sustained weight loss
Diabetologia (2012) 55:256582
In healthy humans, CCK released from EECs enters the circulation and peaks in concentration from 6 to 15 pmol/L at ~90120 min postprandial depending on fat content and meal form 157,158
To reduce risk, patients should ask the pharmacy to label doses in both mg and mL, provide the correct syringe size (typically insulin syringes marked in units), and supply written dosing instructions
10% discount coupon with newsletter subscription
[123] suggested that Dermatophagoides pteronyssinus (Der p) SCIT increases the frequency of Treg cells and that its therapeutic effects are negatively correlated with the frequency of antigen-specific CD38 + B cells
:format(webp))
